|
|
Rescue Therapies for Asthma
Although asthma treatments are widely available, between one-third and one-half of patients continue to have symptoms that regularly interfere with everyday life. These asthma-related symptoms and exacerbations result in almost 2 million emergency department visits each year, which often lead to inpatient hospital stays. Thus, there is a clear need for ongoing education about asthma management, particularly when there are significant changes in treatment recommendations or therapeutic options.... |
|
|
Best of ACTHIV® 2023: HIV 101: Pathogenesis
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this activity will describe HIV infection and viral dynamics, define how viral dynamics impact management of antiretroviral therapy, and describe current progress in area of HIV cure/remission.
Describe HIV infection and viral dynamics
Define how viral dynamics impact management of antiretroviral therapy.
Describe current progress in area of... |
|
|
Best of ACTHIV® 2023: Hepatitis B in People with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will examine best practices for evaluating people with HBV and HIV and will review the risk of liver complications associated with HBV viremia in people with HIV.
Describe best practices for evaluating people with HBV and HIV
Appraise the risk of liver complications associated with HBV viremia in people with HIV |
|
|
Best of ACTHIV® 2023: Diabetes Management and Weight Loss in People with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module discusses how to determine an appropriate diabetes medication regimen for patients with HIV and how to select an appropriate weight loss medication option for patients with HIV.
Determine an appropriate diabetes medication regimen for patients with HIV
Select an appropriate weight loss medication option for patients with HIV |
|
|
Best of ACTHIV® 2023: Approaches to ART Optimization in the Virally Suppressed Patient
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will provide guidance on when to consider an ART change in a virally suppressed person, and the use of 2-drug regimens.
Assess when to consider ART change in a virally suppressed person
Appraise when a 2-drug regimen is appropriate, and when it may be contraindicated |
|
|
Best of ACTHIV® 2023: Initial ART Regimens for the Newly Diagnosed Patient with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module reviews first-line HIV regimens for newly-diagnosed patients with HIV including side effects, discusses rapid ART initiation in newly-diagnosed patients, explores adherence challenges on oral ART and use of long-acting ART, and provides guidance on initial ART if seroconversion occurs on long-acting PrEP.
Review first-line HIV regi... |
|
|
Best of ACTHIV® 2023: Syphilis and Its Management Among Persons with HIV: Case-Based Approaches
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will utilize cases to illustrate when syphilis titers should be performed to trend response to treatment, the interpretation of syphilis titers, how to identify when there has been a serologic treatment failure and what to do about it, and determining when a lumbar puncture is necessary.
Describe when syphilis titers should be per... |
|
|
Crucial Conversations in Pharmacy Practice: Improving Patient Outcomes in Shingles Management
Shingles management"or more specifically, the prevention of shingles (caused by varicella zoster virus; VZV)"is crucial to help preserve quality of life, particularly for older adults. Updated immunization recommendations for recombinant zoster vaccine (RZV) now include updated guidance for adults with compromised immune systems in addition to older adults. Pharmacists play a key role in the interprofessional team with appropriate identification, recommendation, and administration ... |
|
|
Clinical Updates in Chronic Graft-versus-Host Disease and Applications for Academic and Community Practice
Target Audience
The target audience for this activity are hematologists, oncologists, immunologists, and bone-marrow transplant specialists.
Program Overview
Chronic graft-versus-host disease (cGvHD) is a common, multi-symptom complication of allogeneic transplantation that severely affects patient well-being. While the medical systems and resources differ between academic and community healthcare settings, clinicians practicing in both environments would benefit from education about rece... |
|
|
Hitting The Bullseye in NSCLC
Lung cancer is the second most common cancer in both men and women and is the leading cause of cancer-related deaths. The majority of lung cancer cases are categorized as NSCLC, which has a low overall 5-year survival rate, especially when it is diagnosed at advanced, unresectable stages. Recent advances in the treatment landscape have yielded promising improvements in progression-free survival and overall survival; however, outcomes are dependent on numerous factors, including the evaluation ... |
|
|
Ready for a Closeup: Differentiating Inadequate Response and Emotional Blunting During Treatment for Major Depressive Disorder
Major depressive disorder (MDD) can have a significant impact on your patients’ lives. However, MDD is not just about feeling “down.” It’s a life-threatening condition that is a leading cause of suicide. Fortunately, there are a variety of effective therapies; however, many patients may experience an inadequate response to treatment and others may have experience anhedonia or reduced emotional responsiveness (ie, emotional blunting) associated with both selective serotonin reuptake inh... |
|
|
Applying Evolving Targeted Therapy in Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a biologically heterogeneous hematologic malignant neoplasm with a 5-year survival rate of 30%. Hematologist, Brian Jonas, MD, PhD, UC Davis Comprehensive Cancer, discusses standard induction, consolidation, and maintenance therapy, as well as factors to consider in individualizing intensive therapy in fit and unfit patients. Dr. Jonas presents safety and efficacy data for approved and emerging therapies that target BCL-2, FLT-3 ITD/TDK, CD33, CD47, IDH1/2, E-se... |
|
|
Contemporary Issues in the Management of Patients With Primary Biliary Cholangitis: An Interprofessional Approach
An interprofessional faculty of gastroenterology clinicians discuss real-world issues in managing patients with primary biliary cholangitis. Two mini-lectures serve as the foundation for understanding the diagnostic evaluation and risk factors of primary biliary cholangitis. Three cases foster a robust discussion, among the 5 faculty, of clinical decision-making around the roles, benefits, and limitations of approved and investigational pharmacologic treatment options. The program format foste... |
|
|
It Takes a Village: Working Together to Reduce Racial Inequities in Maternal Morbidity and Mortality
Maternal morbidity and mortality rates are unacceptably high in the United States (US). In fact, Black women are two to three times more likely to die from pregnancy-related causes than white women, prompting the US Department of Health and Human Services to state that maternal deaths are a public health crisis. What can you do to address these inequities in maternal health? Two experts in this field will discuss the latest data on maternal deaths and frame practical and supportive strategies ... |
|
|
LET'S TALK: Tackling Complex Issues Regarding SM-AHN Management A Monday Morning Joe Online Educational Activity
Systemic mastocytosis (SM) is a group of rare disorders characterized by the accumulation of mast cells in internal tissues and organs. The pathogenesis of SM is linked to a characteristic exon 17 D816V mutation of the KIT gene. Systemic mastocytosis with associated hematologic neoplasms (SM-AHN) is an advanced subtype of SM that is associated with a shortened median survival time. Recent advances in the SM therapeutic landscape have led to the development of KIT-targeted treatment options; ho... |
|
|
Promoting Equitable Oral Health in Patients of Color
There are many vulnerable and underserved populations in oral health. Gaps in health and health care are often caused by the disconnect between medical and dental care and a fragmented system that has left 74 million people without dental insurance, leading to knowledge gaps and a lack of dental-medical collaboration and coordination in patient care. These issues are exacerbated in patients of color, often due to interpersonal racism.
This CME Outfitters BriefCase will feature patient case ... |
|
|
Irregular Care: Racial Inequities in the Management of Cardiac Rhythm Disorders
Structural racism and classism leads to many of the social determinants of health (SDoH) that cause disparities in cardiovascular (CVD) care, such as unequal preventative care, heart arrythmia treatment, and research inclusion. Interpersonal racism, including unconscious bias, worsens disproportionate CVD care, and is also a stand-alone factor for this health inequity. Underrepresented minority (URM) patients – particularly Black/African American individuals – are less likely to receive, b... |
|
|
Putting Together Clues in HIV, CVD, T2D, and CKD
As people with HIV live longer, they can develop common comorbidities affecting aging patients, such as type 2 diabetes (T2D), cardiovascular disease (CVD), and chronic kidney disease (CKD). Further, weight gain may be seen in some patients, though the role of antiretroviral therapy (ART) is still under investigation. Clinicians should become familiar with treatment guidelines, drug-drug interactions, and techniques for shared decision-making to manage aging patients with HIV and common comorb... |
|
|
Case Studies in HIV Prevention and Treatment of Persons Who Use Drugs
Educational Need:
Prevention of HIV in individuals with substance use disorder (SUD) is vitally important from a public health perspective. People with SUD are significantly more vulnerable to contracting HIV, attributable to behaviors such as sharing needles and injection equipment, engaging in condomless sex, and impaired judgement. Furthermore, substance use can negatively affect medication adherence and engagement in healthcare, making it more challenging to treat and manage HIV in this ... |
|
|
Secrets of Egypt & the Nile: Joint Medical/Dental Symposium Confronting Healthcare Needs
Uncover Egypt’s ancient secrets with PES for 11 nights on this bucket list adventure! Visit iconic landmarks, temples, and monuments and cruise the Nile in a manner once reserved for pharaohs aboard the luxurious, 72-guest AmaDahlia.
Joint Medical/Dental Symposium Confronting Healthcare Needs
CME/CE Lecture Seminars for Medical, Dental, Nursing, and Allied Healthcare Professionals
This Seminar is planned for 14 Continuing Education Credit Hours.
CME/CE Professional Seminar Fee:... |
|
|
Surgery or Biologic for Nasal Polyps? A Close Look at the Evidence
Target Audience
The intended audience for this program is ENTs, allergists, immunologists, specialty nurse practitioners and PAs, and other clinicians involved in the management of patients with nasal polyps.
Program Overview
As management strategies for nasal polyps (NPs) have evolved, patients whose NPs do not respond to initial treatment, who are ineligible for systemic corticosteroids, or whose NPs recur after initial surgery often undergo repeated surgeries, with high associated cost... |
|
|
Nursing Management of Tumor Lysis Syndrome
STATEMENT OF NEED
Tumor lysis syndrome (TLS) is an oncological emergency that occurs when massive tumor lysis causes the rapid release of intracellular components into the bloodstream. Electrolyte imbalances characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia may be severe enough to cause acute renal failure, cardiac arrhythmias, seizures, and even death. Current advances in cancer therapies can increase the incidence of TLS; therefore, identification of patien... |
|
|
CME Escape Room: Putting Together Clues in HIV, CVD, T2D, and CKD: Escaping Management Mishaps
Target Audience
The educational design of this activity addresses the needs of US and ex-US infectious disease and HIV specialist physicians, NPs, and PAs involved in the treatment of patients with HIV.
Program Overview
As people with HIV live longer, they can develop common comorbidities affecting aging patients, such as type 2 diabetes (T2D), cardiovascular disease (CVD), and chronic kidney disease (CKD). Further, weight gain may be seen in some patients, though the role of antiretrovir... |
|
|
Monitor Patients with Carpal Tunnel Syndrome and Catch Transthyretin Cardiomyopathy Early in the Course
Target Audience
Healthcare providers in internal medicine, family medicine, surgery, cardiology, neurology, and healthcare professionals caring for patients with carpal tunnel syndrome and/or heart failure.
Program Overview
ATTR is a type of amyloidosis that affects the heart as well as other tissues such as the synovium of carpal tunnel. Bilateral carpal tunnel syndrome proceeds the symptoms of ATTR cardiomyopathy by a number of years. Topics on when to refer patients with carpal tunnel ... |
|
|
Are You Seeing the Whole Picture? Test Your Skills for Intensifying Therapy in Patients with Type 2 Diabetes
The management of type 2 diabetes (T2D) has evolved rapidly with new agents and changing recommendations. Do you see the whole picture when selecting therapy for your patients? Engage in this interactive clinical case challenge to see whether your treatment selection aligns with guideline recommendations and account for cardiovascular disease risks, patient-centric factors, and weight management. |
|
|
Delivering Culturally Competent Care: Managing Type 2 Diabetes in Diverse Populations
This course presents practical advice for working cross-culturally. It allows participants to practice and improve their communication skills while managing typical clinical problems encountered in persons with type 2 diabetes.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Recognize the differences between the terms "race," "ethnicity," and "culture."
- Employ the Ask, Share, Compare, Negotiate Model with patients in the office... |
|
|
Thymidine Kinase 2 Deficiency: From Diagnostic Odyssey to Timely Diagnosis and Treatment
Mary Kay Koenig, MD, a leader in the management of patients with mitochondrial diseases, delves into the complexities of managing patients with thymidine kinase 2 deficiency (TK2d). In this 1-hour activity, Dr. Koenig shares her insights in the clinical presentation of TK2d through real case studies and offers guidance on overcoming the ‘diagnostic odyssey’ experienced by many patients with mitochondrial disease. She also discusses the clinical criteria for referring patients to specialize... |
|
|
Treatment Considerations in Cutaneous Melanoma: From Early Stage to Late/Advanced Stage
Jason J. Luke, MD, discusses the impact of evolving therapies on the disease burden, survival, and treatment tolerability for patients with cutaneous melanoma. Recent clinical trial results and guideline updates for both perioperative and metastatic cutaneous melanoma are reviewed. To provide patient-centric care, Dr. Luke shares his expert insights and recommendations for individualizing treatment selection and sequencing, as well as providing supportive care and adverse event management. |
|
|
PARP Inhibition as Ovarian Cancer Maintenance Therapy: Improving Patient Outcomes as a Multidisciplinary Team
Ovarian cancer (OC) is often diagnosed at an advanced stage and has generally poor survival rates¬"even after aggressive surgical management and chemotherapy. Without maintenance therapy, approximately 70% of patients relapse within 3 years of treatment. Recent clinical trials of polyadenosine diphosphate-ribose polymerase (PARP) inhibitors have demonstrated substantial efficacy as maintenance therapy for OC patients. Additionally, clinical evidence suggests that daily monitoring of pati... |
|
|
Expanding the Benefit of Quality Improvement Programs: Sustainable Solutions to Achieve Therapeutic Goals for Patients with Myelofibrosis
Achieve measurable changes to improve your patients’ outcomes with this simple, systematic approach for quality improvement for application at any practice setting. Complete an assessment to understand where your practice’s performance falls relative to identified goals, which guides development of personalized action items. Access the framework and tools you need to measure your understanding. |
|
|
Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life
Stay up to date on the evolving risk classification for myelodysplastic syndromes (MDS) and current treatment guidelines for patients with high-risk disease in this self-directed education with leading oncology experts. Expert commentary from Courtney DiNardo, MD from MD Anderson Cancer Center and Dr. Dan Pollyea from the University of Colorado School of Medicine provides insights on emerging therapies that could soon improve management of high-risk MDS. Be ready to incorporate these emerging ... |
|
|
Sustainable Solutions to Achieve Therapeutic Goals for Patients with Myelofibrosis
When it comes to treating your patients with myelofibrosis (MF), are you applying the latest guidance in practice? Evidence shows that it takes an average of 17 years for evidence to change practice but how can we incorporate treatment advances to improve patient outcomes today? This activity looks to bridge the chasm between education and implementation by framing available evidence and guideline recommendations for MF, including diagnosis, risk stratification, JAK inhibition, monitoring resp... |
|
|
Glaucoma Treatments in 2021: Personalizing Patient Needs
This continuing medical education (CE/CME) activity captures content from a roundtable in August.
Activity Description
Based on a roundtable held in August, this supplement summarizes a discussion of the mechanisms of actions and challenges with currently available and novel therapeutics as well as how to personalize glaucoma treatments.
Target Audience
This certified CME/CE activity is designed eye care providers involved in the management of glaucoma and associated disorders. |
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Presentations in the Primary Care Setting
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options and that treatment is initiated as early as possible in the disease process. PH is classified into 5 c... |
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Presentation and Evaluation by Pulmonary Specialist
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options and that treatment is initiated as early as possible in the disease process. PH is classified into 5 c... |
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Treatment Decisions and Therapy Initiation by Pulmonary Hypertension Specialist
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options and that treatment is initiated as early as possible in the disease process. PH is classified into 5 c... |
|
|
Cases in Practice: Applying Proposed Care Pathways for Interdisciplinary Collaboration to the Management of Nasal Polyps
Target Audience
The intended audience for this program is ENTs, allergists, immunologists, specialty nurse practitioners and physician assistants, and other clinicians involved in the management of patients with nasal polyps (NPs).
Program Overview
Clinicians on the frontlines of care for chronic rhinosinusitis with nasal polyps " including ear, nose, and throat specialists (ENTs) and allergists-- are largely unaware of the underlying pathophysiology driven by type 2 (T2) inflammatio... |
|
|
Recognition and Referral: Best Practices for Managing Patients with GA
Patients with advanced dry age-related macular degeneration can present with geographic atrophy (GA), a disease that is progressive and increases with age. Although there is no treatment approved by the FDA that halts or reverses GA, a number of drugs in the pipeline are designed to address GA progression, hoping to succeed where previous drug candidates failed. This series of regional, interactive, virtual symposia are designed to educate eye care providers on the importance of diagnosis and ... |
|
|
Making the Case to Use JAK Inhibitors for Rheumatoid Arthritis"Who, What, When, and How
Target Audience
This activity has been designed to address the educational needs of rheumatology clinicians. It may also benefit other clinicians involved in the management of patients with rheumatoid arthritis (RA).
Program Overview
Join Dr Rigby and Dr Troum as they discuss the use of Janus kinase (JAK) inhibitors for the treatment of RA. In this program they will discuss the latest post-hoc analysis of the ORAL Surveillance trial, which shows which patients can safely and effectively u... |
|
|
The Critical Role of Managed Care Pharmacists in Optimizing Treatment of Iron Deficiency in Patients with Heart Failure
Despite evidence-based interventions to prevent or manage heart failure (HF), poor HF-related outcomes persist as evidenced by the number of preventable HF-related hospitalizations and high readmission rates. Moreover, the economic burden that HF places on the health care system is significant. Pharmacists can improve adherence to guideline recommendations for the use of intravenous (IV) iron therapy for patients with HF and iron deficiency (ID) and develop treatment pathways and implement for... |
|
|
8th Annual National Hospitalist Conference
The 8th Annual National Hospitalist Conference on November 18-21, 2024 at the Hyatt Regency Coconut Point Resort & Spa is designed to provide attendees with the information and skills to improve the care of hospitalized patients. This conference has been accredited for up to 16 CME credits.
The conference's focus is on the practical management of problems commonly encountered in hospital medicine. An emphasis will be placed on recent advances, up-to-date practices, and guidelines f... |
|
|
Case Studies in HIV Resistance Testing and Treatment " Experienced Patients
Educational Need:
Through a series of patient cases, participants will explore the complexities of managing HIV infection in patients who have been treated with multiple different HIV regimens. Participants will engage in real-life case studies that will provide valuable insight into the intricacies of HIV treatment and resistance testing. Our faculty educators will discuss commonly encountered challenges faced by the care team and their treatment-experienced patients with HIV and offer real... |
|
|
Putting Patients First: Best Practices for Neurotrophic Keratitis Diagnosis and Treatment
This previously recorded satellite symposium features an engaging presentation on the potential causes of neurotrophic keratitis, how to differentiate it from similar diseases, and when referrals may be necessary. Treatment options will also be discussed, including the mechanisms of action of newer therapies and when they should be introduced.
Case discussions and audience question-and-answer session were also recorded. |
|
|
Dermatology Clinical Case Challenge: Can You Diagnose this Patient?
How are your diagnostic skills for identifying inflammatory skin conditions? In just 10 minutes, learners navigate through three real-world cases and respond to questions relative to possible next steps in diagnostic procedures considerate of each patient’s history and perspective, physical examination findings, lab results, and skin biopsy results. Diagnostic conclusions are revealed after reviewing all cases. Hear faculty insights on the implications of learner decisions along with ration... |
|
|
Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents
Join Nathan M. Radcliffe, MD, and Justin Schweitzer, OD, FAAO, as they discuss the ways in which novel therapeutics may help to overcome the challenges and limitations associated with currently available pharmacologic treatment options for ocular hypertension and primary open-angle glaucoma. |
|
|
Answering The Call in Nonadvanced Systemic Mastocytosis
Target Audience
The design of this activity addresses the needs of clinical immunologists/allergists, dermatologists, gastroenterologists, hematologists, and other specialist clinicians who diagnose or manage nonadvanced systemic mastocytosis (SM).
Program Overview
Nonadvanced SM is a challenging disorder to diagnose and manage due to the heterogeneity of symptoms, anaphylactic triggers, and complicated therapeutic paradigm. In this unique and engaging Call-a-Colleague program, a panel of... |
|
|
Best Practices in Multiple Myeloma Care: Opportunities to Improve Outcomes in Community Settings
As nurses and APPs are well positioned to educate, support, and coordinate care for patients with multiple myeloma, having insight into the evolving trajectory of the disease will enhance their ability to provide quality patient care and identify and eliminate barriers. Addressing barriers to care remains key in ensuring access to novel therapies and improving quality of life. Having an understanding of the advances and increasing complexity of care of the patient with multiple myeloma will pr... |
|
|
Can You Compete in Early Cancer Detection
This activity is an informative and engaging presentation about blood-based multi-cancer early detection MCED screening in the primary care setting. Drs. Massart, Vega, and Whittington will provide key data related to current gaps in cancer surveillance, the science and data behind MCEDs, and information on how to implement MCED screening into practice. |
|
|
The Art of Ophthalmology Medicine: Individualizing Therapy in Neovascular Age Related Macular Degeneration in an Era of Expanded Treatment Options; nAMD Day in the Life
Target Audience
This initiative is designed to meet the educational needs of retina/ophthalmology, optometry, managed care, primary care/internal medicine, diabetes education, and cardiology/endocrinology sub-specialties.
Program Overview
This enduring activity focuses on individualizing therapy for the treatment of neovascular age-related macular degeneration (nAMD). Providers will learn about the safety, efficacy, and durability of established and emerging nAMD therapies, as well as tec... |
|
|
Improving Diagnosis and Management of Chronic Idiopathic Constipation Across Diverse Patient Populations
Can you differentiate between chronic idiopathic constipation (CIC) and other conditions characterized by constipation to ensure your patients receive timely and appropriate interventions? Access these educational resources and tools to help you enhance diagnostic processes, management strategies, and multidisciplinary care. Then share this invaluable educational content with your team by using the downloadable discussion guides and slide decks to initiate meaningful conversations. Do you have... |
|